Cargando…
Alterations in fecal short-chain fatty acids in patients with irritable bowel syndrome: A systematic review and meta-analysis
BACKGROUND: Recent studies indicate that gut microbiota disorders potentially contribute to the pathogenesis of irritable bowel syndrome (IBS), which can be partly reflected by fecal short-chain fatty acids (SCFAs) generated from gut microbiota. Previous studies on SCFA alterations in patients with...
Autores principales: | Sun, Qinghua, Jia, Qiong, Song, Lijin, Duan, Liping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6408019/ https://www.ncbi.nlm.nih.gov/pubmed/30762787 http://dx.doi.org/10.1097/MD.0000000000014513 |
Ejemplares similares
-
Sex‐based differences in fecal short‐chain fatty acid and gut microbiota in irritable bowel syndrome patients
por: Sun, Qing Hua, et al.
Publicado: (2021) -
Changes in fecal short‐chain fatty acids following fecal microbiota transplantation in patients with irritable bowel syndrome
por: El‐Salhy, Magdy, et al.
Publicado: (2020) -
Associations of Fecal Short Chain Fatty Acids With Colonic Transit, Fecal Bile Acid, and Food Intake in Irritable Bowel Syndrome
por: Waseem, Mohammed Rayyan, et al.
Publicado: (2022) -
The Role of Short Chain Fatty Acids in Irritable Bowel Syndrome
por: Jiang, Wenxi, et al.
Publicado: (2022) -
2073: Fecal bile acids, fecal short-chain fatty acids and the intestinal microbiota in patients with irritable bowel syndrome (IBS) and control volunteers
por: Shin, Andrea, et al.
Publicado: (2018)